The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pre-clinical evaluation of the PP2A inhibitor LB-100 for the treatment of lapatinib resistant HER2-positive breast cancer.
 
Neil Conlon
No Relationships to Disclose
 
Martina McDermott
No Relationships to Disclose
 
Brigid Browne
No Relationships to Disclose
 
Sandra Roche
No Relationships to Disclose
 
Fiona O'Neill
No Relationships to Disclose
 
Justine Meiller
No Relationships to Disclose
 
Alex J. Eustace
No Relationships to Disclose
 
Denis Collins
No Relationships to Disclose
 
Norma O'Donovan
No Relationships to Disclose
 
John Crown
Honoraria - Amgen; Boehringer Ingelheim; Eisai; Genomic Health; Pfizer; Puma Biotechnology; Seagen; Vertex
Speakers' Bureau - Eisai; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; MSD; Pfizer; Roche